Rafael Zenon Wagner has added a photo to the pool:
We’ve always been looking for a secluded, shady spot under the palm trees on the beach. We found it on Koh Chang in Thailand.
"Our objective is for Russia to withdraw permanently from Azawad and beyond, from all of Mali," a rebel spokesman told AFP.
‘Buzkashi is a brutal sport that dates back to Genghis Khan. These Tajik players are trying to grab the body of a goat and drop it over a goal line. It’s every man for himself – and games can last six hours’
I can’t remember where I first read about buzkashi. Played across central Asia, the sport is thought to date back to the time of Genghis Khan. It involves large groups of men on horseback trying to grab the headless body of a goat and keep control of it long enough to drop it over a line marked on the ground. There are no teams, it’s every man for himself, and games can last six hours.
My projects often involve heightened colour, but when I decided I wanted to get back to the basics of light and tone and do a black and white series, this subject seemed to fit. A lot of the buzkashi footage I’d found was from Tajikistan, so I went there, hiring a local fixer to help deal with the logistics as news of the time and place of matches tends to travel by word of mouth just a few days in advance.
Continue reading...
In de experimentele debuutroman Je zit op een stoel gebeurt op het eerste gezicht niet veel. Toch weet Bob Vanden Broeck de lezer te grijpen met een hypnotiserende monoloog die de verbeelding in gang zet.
/s3/static.nrc.nl/wp-content/uploads/2026/04/29153205/300426BOE_2033391549_Stoel.jpg)
An anonymous reader quotes a report from NBC News: The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. It's the latest move by the Trump administration signaling a shift in policy toward treatments that also give users a high -- coming a day after the Justice Department said it would ease restrictions on state-licensed medical marijuana.
UK-based biotech company Compass Pathways said Friday it has received an expedited review for its experimental form of synthetic psilocybin for treatment-resistant depression. In a press release the company cited two large, phase 3 studies that had "generated positive data." Usona Institute, headquartered in Wisconsin, also said it's received a voucher for its work with psilocybin to treat major depressive disorder. In an email, a Usona spokesperson said the company expects the review process to last one to two months after it submits its application. "The voucher expedites the timeline only; it does not alter scientific or regulatory standards," the spokesperson wrote. New York-based Transcend Therapeutics has also been granted a priority review voucher for its experimental drug methylone for PTSD, Blake Mandell, the company's chief executive officer, said. "There's a battle still raging in their mind that we don't fully understand biochemically," FDA Commissioner Marty Makary said. "When you see something that looks promising for a community that is suffering with mental health illness, despair and suicidal ideation, you can't help but recognize that."
Makary told NBC News that with the priority voucher program, the agency could potentially approve the first psychedelic drug by the end of summer.
UK-based biotech company Compass Pathways said Friday it has received an expedited review for its experimental form of synthetic psilocybin for treatment-resistant depression. In a press release the company cited two large, phase 3 studies that had "generated positive data." Usona Institute, headquartered in Wisconsin, also said it's received a voucher for its work with psilocybin to treat major depressive disorder. In an email, a Usona spokesperson said the company expects the review process to last one to two months after it submits its application. "The voucher expedites the timeline only; it does not alter scientific or regulatory standards," the spokesperson wrote. New York-based Transcend Therapeutics has also been granted a priority review voucher for its experimental drug methylone for PTSD, Blake Mandell, the company's chief executive officer, said. "There's a battle still raging in their mind that we don't fully understand biochemically," FDA Commissioner Marty Makary said. "When you see something that looks promising for a community that is suffering with mental health illness, despair and suicidal ideation, you can't help but recognize that."
Makary told NBC News that with the priority voucher program, the agency could potentially approve the first psychedelic drug by the end of summer.
Read more of this story at Slashdot.
De grote natuurbrand bij 't Harde is onder controle. De brandweer heeft besloten Nederland gecontroleerd te laten uitbranden.
"Voor Nederlandse begrippen is dit een extreem grote brand", legt Landelijk Coördinator Natuurbrandbeheersing Edwin Kok uit. "Het klinkt misschien heftig, maar dan is dit toch echt de beste oplossing. Op deze manier kunnen we voorkomen dat de brand overslaat naar bijvoorbeeld België of de Noordzee."
Er is geen NL Alert verstuurd. Nederlanders moeten stilzitten en hun lot accepteren.
&
